Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited
Your view on BDMD
Overview
What the company does, where it operates, and who runs it.
About Baird Medical Investment Holdings Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Haimei Wu
- Headquarters
- CN
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Haimei Wu
- Headquarters
- CN
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps.
Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Baird Medical Investment Holdings Limited, and the rating behind it. BDMD last traded at $1.10; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Baird Medical Investment Holdings Limited. Starting points for Baird Medical Investment Holdings Limited: EPS -$0.39, beta -1.14 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Baird Medical Investment Holdings Limited. Baird Medical Investment Holdings Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Baird Medical Investment Holdings Limited. Trailing twelve-month EPS for Baird Medical Investment Holdings Limited stands at -$0.39. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Baird Medical Investment Holdings Limited. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Baird Medical Investment Holdings Limited valued side by side against its closest peers. Baird Medical Investment Holdings Limited is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Baird Medical Investment Holdings Limited, and how their positions are changing. At a $46.4M market value, institutional positions materially move Baird Medical Investment Holdings Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Baird Medical Investment Holdings Limited executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Baird Medical Investment Holdings Limited. Baird Medical Investment Holdings Limited is a $46.4M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Baird Medical Investment Holdings Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Baird Medical Investment Holdings Limited. Coverage tracks Baird Medical Investment Holdings Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.